Compound information
- Natural Products
- ZC1649555
- Molecular Formula
- C10H9ClF3NO
- Molecular Weight
- 251.032476248 g/mol
- Structure
-
- IUPAC Name
- (2R)-2-chloro-N-[4-(trifluoromethyl)phenyl]propanamide
- InChI
- InChI=1S/C10H9ClF3NO/c1-6(11)9(16)15-8-4-2-7(3-5-8)10(12,13)14/h2-6H,1H3,(H,15,16)/t6-/m1/s1
- InChI Key
- FPRVGJQLWPFYOU-ZCFIWIBFSA-N
- SMILES
- C[C@@H](Cl)C(=O)Nc1ccc(C(F)(F)F)cc1
- Source
- ZINC000003887330
Warheads
- Halohydrocarbon
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 16 | Ring Count | 1 |
Heteroatom Count | 6 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 1 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 29.1 Å2 | LogP | 3.375 |
LogS | -3.733 | LogD | 3.461 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.139 | Pgp substrate | 0.013 |
HIA | 0.965 | F20 % | 0.992 |
F30 % | 0.983 | Caco-2 | -4.584 |
MDCK | -4.628 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.405 | PPB | 80.828 |
VD | 3.27 | Fu | 1.523 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.999 | CYP1A2 substrate | 0.612 |
CYP2A6 substrate | 0.804 | CYP2B6 substrate | 0.585 |
CYP2C19 inhibitor | 0.888 | CYP2C19 substrate | 0.846 |
CYP2C8 substrate | 0.684 | CYP2C9 inhibitor | 0.519 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.262 |
CYP2D6 substrate | 0.522 | CYP2E1 substrate | 0.85 |
CYP3A4 inhibitor | 0.052 | CYP3A4 substrate | 0.987 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.136 | CL | 12.952 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.048 | Hepatotoxicity | 0.933 |
Mutagenicity | 0.134 | Rat Oral Acute Toxicity | 0.255 |
FDAMDD | 0.305 | Skin Sensitization | 0.001 |
Carcinogenicity | 0.015 | Eye Corrosion | 0.765 |
Eye Irritation | 0.744 | Respiratory Toxicity | 0.489 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.476 | IGC50 | 3.441 |
LC50FM | 4.665 | LC50DM | 6.279 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.314 | NR-AR-LBD | 0.302 |
NR-AhR | 0.662 | NR-Aromatase | 0.122 |
NR-ER | 0.37 | NR-ER-LBD | 0.436 |
NR-PPAR-gamma | 0.636 | SR-ARE | 0.241 |
SR-ATAD5 | 0.436 | SR-HSE | 0.061 |
SR-MMP | 0.119 | SR-p53 | 0.728 |
Similar covalent drugs
No similar covalent drugs found for this compound.